Improving the Laboratory Diagnosis of M-like Variants Related to Alpha1-Antitrypsin Deficiency
- PMID: 36077263
- PMCID: PMC9456480
- DOI: 10.3390/ijms23179859
Improving the Laboratory Diagnosis of M-like Variants Related to Alpha1-Antitrypsin Deficiency
Abstract
Alpha1-antitrypsin (AAT) is a serine protease inhibitor that is encoded by the highly polymorphic SERPINA1 gene. Mutations in this gene can lead to AAT deficiency (AATD), which is associated with an increased risk of lung and/or liver disease. On the basis of electrophoretic migration, AAT variants are named with capital letters; M (medium) signifies the normal protein. Among pathological variants, the M-like ones represent a heterogeneous group of rare allelic variants that exhibit the same electrophoretic pattern as the M wild-type protein, which makes them difficult to detect with routine methods. In order to avoid their misdiagnosis, the present study defines and validates effective methods for the detection of two pathogenic M-like variants, Mwurzburg and Mwhitstable. Comparison of protein phenotypes using isoelectric focusing of samples that presented the Mwurzburg variant, as revealed by exons 5 sequencing, identified a particular electrophoretic pattern amenable to the Mwurzburg protein. The specific phenotyping pattern was retrospectively validated, thus enabling the detection of 16 patients with Mwurzburg variant among the subjects already tested but not sequenced according to our diagnostic algorithm. The Mwhitstable allele was detected by intron 4 sequencing of SERPINA1 gene. Mwurzburg and Mwhitstable are often misdiagnosed and the introduction of diagnostic improvements can help the clinical management, especially in patients with established lung disease without any other reported risk factors.
Keywords: Mwhitstable; Mwurzburg; SERPINA1 gene; alpha1-antitrypsin; laboratory diagnosis; rare pathogenic variants.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
Molecular diagnosis of alpha1-antitrypsin deficiency: A new method based on Luminex technology.J Clin Lab Anal. 2020 Jul;34(7):e23279. doi: 10.1002/jcla.23279. Epub 2020 Mar 17. J Clin Lab Anal. 2020. PMID: 32181528 Free PMC article.
-
Protein modeling to assess the pathogenicity of rare variants of SERPINA1 in patients suspected of having Alpha 1 Antitrypsin Deficiency.BMC Med Genet. 2019 Jul 15;20(1):125. doi: 10.1186/s12881-019-0852-5. BMC Med Genet. 2019. PMID: 31307431 Free PMC article.
-
Identification and characterisation of eight novel SERPINA1 Null mutations.Orphanet J Rare Dis. 2014 Nov 26;9:172. doi: 10.1186/s13023-014-0172-y. Orphanet J Rare Dis. 2014. PMID: 25425243 Free PMC article.
-
Diagnosis of alpha-1 antitrypsin deficiency: modalities, indications and diagnosis strategy.Rev Mal Respir. 2014 Oct;31(8):729-45. doi: 10.1016/j.rmr.2014.06.001. Epub 2014 Jul 3. Rev Mal Respir. 2014. PMID: 25391508 Review.
-
[Molecular diagnostics of alpha-1-antitrypsin deficiency in clinical practice].Pneumonol Alergol Pol. 2008;76(4):253-64. Pneumonol Alergol Pol. 2008. PMID: 18785130 Review. Polish.
References
-
- Torres-Durán M., Lopez-Campos J.L., Barrecheguren M., Miravitlles M., Martinez-Delgado B., Castillo S., Escribano A., Baloira A., Navarro-Garcia M.M., Pellicer D., et al. Alpha-1 antitrypsin deficiency: Outstanding questions and future directions. Orphanet J. Rare Dis. 2018;13:114. doi: 10.1186/s13023-018-0856-9. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous